Preferred Label : Myotonia, potassium-aggravated;
CISMeF acronym : SNEL;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Myotonia fluctuans; Myotonia permanens; Sodium channel muscle disease; Myotonia congenita, acetazolamide-responsive; Myotonia congenita, atypical;
Included titles and symbols : Laryngospasm, severe neonatal episodic; SNEL;
Description : In a report on the 37th ENMC Workshop, Rudel and Lehmann-Horn (1997) stated that the
sodium channelopathies can be divided into 3 different forms: paramyotonia, potassium-aggravated
myotonia, and periodic paralysis. Potassium-aggravated myotonia includes mild myotonia
fluctuans, severe myotonia permanens, and acetazolamide-responsive myotonia.;
Inheritance : Autosomal dominant;
Molecular basis : Caused by mutation in the type IV, voltage-gated sodium channel, alpha-subunit gene
(SCN4A, 603967.0009);
Laboratory abnormalities : Serum creatine kinase may be increased;
Prefixed ID : #608390;
Origin ID : 608390;
UMLS CUI : C2931826;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
Genes related to phenotype
HPO term(s)
Not associated HPO term(s)
ORDO concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT